PALI
insider transactionsPALISADE BIO, INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
+4.1K
10.0K buy · 5.9K sell
Net value · 365d
$7.5K
$17.8K in · $10.3K out
Sentiment · 365d
Net buying
63% buying · 37% selling
Open-market trades · 365d
4
10.0K buy · 5.9K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Exercise·M
Director
$0
20.2K sh
Own +100%
-
Exercise·M
Director
—
20.2K sh
Own +3%
-
Grant·A
Director
—
592.3K sh
Own +69275%
-
Exercise·M
Director
$0
60.7K sh
Own +100%
-
Exercise·M
Director
—
60.7K sh
Own +4%
-
Grant·A
Director
—
1.5M sh
Own +13972%
-
Grant·A
Director
—
336.9K sh
Own New
-
Exercise·M
Director
$0
20.2K sh
Own +100%
-
Exercise·M
Director
—
20.2K sh
Own +3%
-
Grant·A
Director
—
592.3K sh
Own New
-
Grant·A
Director
—
336.9K sh
Own New
-
Sell·S
Chief Medical Officer
$3.5K
2.0K sh · $1.75
Own -13%
-
Sell·S
CEO, CFO
$6.8K
3.9K sh · $1.75
Own -12%
-
Exercise·M
Chief Medical Officer
$0
8.0K sh
Own +100%
-
Exercise·M
Chief Medical Officer
—
8.0K sh
Own +110%
-
Exercise·M
CEO, CFO
$0
13.3K sh
Own +100%
-
Exercise·M
CEO, CFO
—
13.3K sh
Own +74%
-
Grant·A
Chief Medical Officer
$0
787.0K sh
Own New
-
Grant·A
CEO, CFO
$0
2.0M sh
Own New
-
Buy·P
Director
$8.4K
5.0K sh · $1.67
Own +87%
-
Buy·P
Director
$9.4K
5.0K sh · $1.88
Own +687%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 10, 2026 | Binxian Wei | Exercise M | 20.2K | $0 |
| Jun 10, 2026 | Binxian Wei | Exercise M | 20.2K | — |
| Jun 10, 2026 | Binxian Wei | Grant A | 592.3K | — |
| Jun 10, 2026 | Donald Allen Williams | Exercise M | 60.7K | $0 |
| Jun 10, 2026 | Donald Allen Williams | Exercise M | 60.7K | — |
| Jun 10, 2026 | Donald Allen Williams | Grant A | 1.5M | — |
| Jun 10, 2026 | Jordan Michael Zwick | Grant A | 336.9K | — |
| Jun 10, 2026 | Emil Chuang | Exercise M | 20.2K | $0 |
| Jun 10, 2026 | Emil Chuang | Exercise M | 20.2K | — |
| Jun 10, 2026 | Emil Chuang | Grant A | 592.3K | — |
| Jun 10, 2026 | Robert Baltera Jr. | Grant A | 336.9K | — |
| Feb 12, 2026 | Mitchell Lawrence Jones | Sell S | 2.0K | $3.5K |
| Feb 12, 2026 | John David Finley KEY | Sell S | 3.9K | $6.8K |
| Feb 11, 2026 | Mitchell Lawrence Jones | Exercise M | 8.0K | $0 |
| Feb 11, 2026 | Mitchell Lawrence Jones | Exercise M | 8.0K | — |
| Feb 11, 2026 | John David Finley KEY | Exercise M | 13.3K | $0 |
| Feb 11, 2026 | John David Finley KEY | Exercise M | 13.3K | — |
| Feb 9, 2026 | Mitchell Lawrence Jones | Grant A | 787.0K | $0 |
| Feb 9, 2026 | John David Finley KEY | Grant A | 2.0M | $0 |
| Jan 16, 2026 | Donald Allen Williams | Buy P | 5.0K | $8.4K |
| Jan 9, 2026 | Donald Allen Williams | Buy P | 5.0K | $9.4K |
About PALI insider trading
This page tracks insider transactions for PALISADE BIO, INC. (PALI) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.